Microbix Expands Pandemic Test Controls (QAPs™) Portfolio

NEXT STORY
Quipt Announces Strategic Acquisition of Biomedical Services Company in the Southeastern United States
PREV STORY
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Betterbrand’s Retail Migration Begins at Earthbar

author_avatar
NASDAQ Market News

Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisation and, if approved, the delisting of its ordinary shares in London and the direct listing of common shares in the new parent company of the Tiziana group on NASDAQ

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

ROCKVILLE, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a ...

author_avatar
NASDAQ Market News